A detailed history of Avestar Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Avestar Capital, LLC holds 8,843 shares of ABT stock, worth $1.04 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
8,843
Previous 7,870 12.36%
Holding current value
$1.04 Million
Previous $817,000 23.38%
% of portfolio
0.11%
Previous 0.08%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$100.07 - $118.13 $97,368 - $114,940
973 Added 12.36%
8,843 $1.01 Million
Q2 2024

Aug 08, 2024

SELL
$100.73 - $112.44 $14,807 - $16,528
-147 Reduced 1.83%
7,870 $817,000
Q1 2024

May 10, 2024

BUY
$109.52 - $120.96 $207,211 - $228,856
1,892 Added 30.89%
8,017 $911,000
Q4 2023

Feb 12, 2024

BUY
$90.19 - $110.4 $128,881 - $157,761
1,429 Added 30.43%
6,125 $674,000
Q3 2023

Oct 20, 2023

BUY
$95.53 - $114.62 $1,146 - $1,375
12 Added 0.26%
4,696 $454,000
Q2 2023

Aug 01, 2023

SELL
$100.78 - $112.29 $64,801 - $72,202
-643 Reduced 12.07%
4,684 $510,000
Q1 2023

Apr 20, 2023

SELL
$96.86 - $114.01 $45,427 - $53,470
-469 Reduced 8.09%
5,327 $539,000
Q4 2022

Jan 20, 2023

BUY
$95.06 - $111.52 $30,609 - $35,909
322 Added 5.88%
5,796 $0
Q3 2022

Oct 26, 2022

SELL
$96.76 - $112.03 $156,267 - $180,928
-1,615 Reduced 22.78%
5,474 $530,000
Q2 2022

Jul 28, 2022

BUY
$102.07 - $123.37 $63,079 - $76,242
618 Added 9.55%
7,089 $770,000
Q1 2022

Apr 26, 2022

BUY
$114.02 - $139.04 $73,656 - $89,819
646 Added 11.09%
6,471 $766,000
Q4 2021

Feb 01, 2022

SELL
$115.53 - $141.46 $28,420 - $34,799
-246 Reduced 4.05%
5,825 $820,000
Q3 2021

Nov 09, 2021

BUY
$116.66 - $129.06 $69,179 - $76,532
593 Added 10.83%
6,071 $717,000
Q2 2021

Aug 03, 2021

SELL
$105.79 - $124.53 $7,616 - $8,966
-72 Reduced 1.3%
5,478 $635,000
Q1 2021

May 03, 2021

SELL
$108.84 - $128.23 $101,330 - $119,382
-931 Reduced 14.37%
5,550 $674,000
Q4 2020

Feb 01, 2021

BUY
$105.0 - $114.42 $46,200 - $50,344
440 Added 7.28%
6,481 $710,000
Q3 2020

Oct 29, 2020

SELL
$91.64 - $111.29 $523,172 - $635,354
-5,709 Reduced 48.59%
6,041 $658,000
Q2 2020

Jul 29, 2020

BUY
$76.57 - $98.0 $531,166 - $679,826
6,937 Added 144.13%
11,750 $1.07 Million
Q1 2020

May 12, 2020

SELL
$62.82 - $91.86 $30,027 - $43,909
-478 Reduced 9.03%
4,813 $380,000
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $37,841 - $42,126
482 Added 10.02%
5,291 $459,000
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $25,943 - $28,130
317 Added 7.06%
4,809 $402,000
Q2 2019

Aug 06, 2019

BUY
$72.88 - $85.0 $2,405 - $2,805
33 Added 0.74%
4,492 $356,000
Q1 2019

May 09, 2019

SELL
$66.22 - $80.06 $92,906 - $112,324
-1,403 Reduced 23.93%
4,459 $336,000
Q4 2018

Jan 25, 2019

SELL
$65.56 - $74.27 $49,366 - $55,925
-753 Reduced 11.38%
5,862 $404,000
Q3 2018

Oct 23, 2018

BUY
$60.81 - $73.36 $50,837 - $61,328
836 Added 14.47%
6,615 $461,000
Q2 2018

Aug 10, 2018

SELL
$57.57 - $63.54 $17,731 - $19,570
-308 Reduced 5.06%
5,779 $326,000
Q1 2018

May 10, 2018

BUY
$56.27 - $63.62 $33,987 - $38,426
604 Added 11.02%
6,087 $348,000
Q4 2017

Feb 14, 2018

BUY
$53.68 - $57.47 $294,327 - $315,108
5,483
5,483 $293,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Avestar Capital, LLC Portfolio

Follow Avestar Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avestar Capital, LLC with notifications on news.